drugset / Trial / NCT00606268
A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The study will evaluate PK and safety of two dose levels of Micafungin (FK463) as Antifungal prophylaxis in children and adolescents undergoing HSCT
Timeline
- Start
- 2007-11
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Micafungin | Peptide | 1 mg/kg | — |
| Subject | Micafungin | Peptide | 1.5 mg/kg | — |